Filing metadata

Accession number
0000950170-23-066787
Form type
Form 3
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Nov 29, 2023
Reporting period
Nov 27, 2023
Description
Initial ownership

Explore SEC Filings Hub